<DOC>
	<DOCNO>NCT01556555</DOCNO>
	<brief_summary>This study aim prospectively evaluate clinical utility Spyglass sclerosing cholangitis patient undergo endoscopic retrograde cholangiopancreaticography ( ERCP ) . Fifty patient definite diagnosis sclerosing cholangitis clinical indication ERCP September 2008 onwards investigate peroral cholangioscopy use Spyglass direct visualization system . Clinical data patient collected time ERCP include information Primary sclerosing cholangitis ( PSC ) inflammatory bowel disease ( IBD ) , serum liver function test indication ERCP . A structured data collection form include information Majoie Score , macroscopic feature bile duct cholangioscopy , quality investigation , technical difficulty , overall judgment whether abnormality observe benign malignant complete endoscopist conjunction procedure .</brief_summary>
	<brief_title>Clinical Utility Spyglass System Primary Sclerosing Cholangitis ( PSC )</brief_title>
	<detailed_description />
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>sclerosing cholangitis indication ERCP Over 18 year inform consent Not able sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Sclerosing cholangitis</keyword>
	<keyword>Spyglass</keyword>
	<keyword>Endoscopic retrograde cholangiopancreaticography</keyword>
</DOC>